-
$2,000 Read More Botulism – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Botulism - Pipeline Review, H1 2016’, provides an overview of the Botulism pipeline landscape. The report provides comprehensive information on the therapeutics under development for Botulism, complete with analysis by stage of development, drug target, mechanism of acti... -
$2,000 Read More Cholera – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Cholera - Pipeline Review, H1 2016’, provides an overview of the Cholera pipeline landscape. The report provides comprehensive information on the therapeutics under development for Cholera, complete with analysis by stage of development, drug target, mechanism of action ... -
$2,000 Read More Typhoid Fever – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Typhoid Fever - Pipeline Review, H1 2016’, provides an overview of the Typhoid Fever pipeline landscape. The report provides comprehensive information on the therapeutics under development for Typhoid Fever, complete with analysis by stage of development, drug target, me... -
$2,000 Read More Lyme Disease – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Lyme Disease - Pipeline Review, H1 2016’, provides an overview of the Lyme Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Lyme Disease, complete with analysis by stage of development, drug target, mecha... -
$2,000 Read More Bacterial Vaginosis – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Bacterial Vaginosis - Pipeline Review, H1 2016’, provides an overview of the Bacterial Vaginosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Bacterial Vaginosis, complete with analysis by stage of developmen... -
$2,000 Read More Ragweed Allergy – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Ragweed Allergy - Pipeline Review, H1 2016’, provides an overview of the Ragweed Allergy pipeline landscape. The report provides comprehensive information on the therapeutics under development for Ragweed Allergy, complete with analysis by stage of development, drug targ... -
$2,000 Read More Birch Pollen Allergy – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Birch Pollen Allergy - Pipeline Review, H1 2016’, provides an overview of the Birch Pollen Allergy pipeline landscape. The report provides comprehensive information on the therapeutics under development for Birch Pollen Allergy, complete with analysis by stage of develop... -
Read More Diabetic Neuropathic Pain – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Diabetic Neuropathic Pain - Pipeline Review, H1 2016’, provides an overview of the Diabetic Neuropathic Pain pipeline landscape. The report provides comprehensive information on the therapeutics under development for Diabetic Neuropathic Pain, complete with analysis by s... -
$2,000 Read More House Dust Mite Allergy – Pipeline Review, H1 2016
Global Markets Direct’s, ‘House Dust Mite Allergy - Pipeline Review, H1 2016’, provides an overview of the House Dust Mite Allergy pipeline landscape. The report provides comprehensive information on the therapeutics under development for House Dust Mite Allergy, complete with analysis by stage o... -
$2,000 Read More Iron Deficiency Anemia – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Iron Deficiency Anemia - Pipeline Review, H1 2016’, provides an overview of the Iron Deficiency Anemia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Iron Deficiency Anemia, complete with analysis by stage of d...
Sorry, there is no ad related to this category!
-
$1,500 Read More Clevexel Pharma SAS – Product Pipeline Review – 2015
Global Markets Direct’s, ‘Clevexel Pharma SAS – Product Pipeline Review – 2015’, provides an overview […]
-
$2,000 Read More Prader-Willi Syndrome (PWS) – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Prader-Willi Syndrome (PWS) – Pipeline Review, H1 2016’, provides an overview of […]
-
$2,000 Read More Candidiasis – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Candidiasis – Pipeline Review, H1 2016’, provides an overview of the Candidiasis […]
-
$6,995 Read More Frontier Pharma: Chronic Obstructive Pulmonary Disease (COPD) – Identifyin...
Chronic Obstructive Pulmonary Disease (COPD) is a progressive disorder associated with chronic inflammation of the […]
-
$1,995 Read More CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Indones...
The report is an essential source of information on and analysis of the healthcare, regulatory […]
-
$2,000 Read More Botulism – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Botulism – Pipeline Review, H1 2016’, provides an overview of the Botulism […]
-
$2,500 Read More Herpes Labialis (Oral Herpes) Global Clinical Trials Review, H1, 2016
This report provides top line data relating to the clinical trials on Herpes Labialis (Oral […]
-
$6,995 Read More Frontier Pharma: Innovative Licensing Opportunities in Non-Hodgkin Lymphoma
Non-Hodgkin Lymphoma (NHL) can be seen as a collection of up to 60 smaller subtypes […]
-
$2,000 Read More Hyperalgesia – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Hyperalgesia – Pipeline Review, H1 2016’, provides an overview of the Hyperalgesia […]
-
$2,000 Read More Colitis – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Colitis – Pipeline Review, H1 2016’, provides an overview of the Colitis […]
